QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
التنسيق: مقال
اللغة:English
منشور في: Elsevier 2020-08-01
سلاسل:Heart Rhythm O2
الموضوعات:
Coronavirus
Electrocardiogram
Hydroxychloroquine
QT interval
Ventricular arrhythmia
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2666501820300751

الانترنت

http://www.sciencedirect.com/science/article/pii/S2666501820300751

مواد مشابهة